NeuBase Therapeutics Price on May 6, 2024

NBSEDelisted Stock  USD 1.62  0.17  9.50%   
If you're considering investing in NeuBase Stock, it is important to understand the factors that can impact its price. As of today, the current price of NeuBase Therapeutics stands at 1.62, as last reported on the 2nd of December, with the highest price reaching 1.83 and the lowest price hitting 1.60 during the day. We have found twenty-three technical indicators for NeuBase Therapeutics, which you can use to evaluate the volatility of the firm. Please verify NeuBase Therapeutics' Risk Adjusted Performance of (0.12), mean deviation of 4.27, and Standard Deviation of 6.12 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
  
NeuBase Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
NBSE
Based on monthly moving average NeuBase Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NeuBase Therapeutics by adding NeuBase Therapeutics to a well-diversified portfolio.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

About NeuBase Therapeutics Stock history

NeuBase Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NeuBase is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NeuBase Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NeuBase Therapeutics stock prices may prove useful in developing a viable investing in NeuBase Therapeutics
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania. Neu Base operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 33 people.

NeuBase Therapeutics Stock Technical Analysis

NeuBase Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of NeuBase Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of NeuBase Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

NeuBase Therapeutics Period Price Range

Low
December 2, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

NeuBase Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

NeuBase Therapeutics December 2, 2024 Market Strength

Market strength indicators help investors to evaluate how NeuBase Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeuBase Therapeutics shares will generate the highest return on investment. By undertsting and applying NeuBase Therapeutics stock market strength indicators, traders can identify NeuBase Therapeutics entry and exit signals to maximize returns

NeuBase Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for NeuBase Therapeutics' price direction in advance. Along with the technical and fundamental analysis of NeuBase Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NeuBase to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in NeuBase Stock

If you are still planning to invest in NeuBase Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeuBase Therapeutics' history and understand the potential risks before investing.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope